NO20075600L - Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens - Google Patents

Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens

Info

Publication number
NO20075600L
NO20075600L NO20075600A NO20075600A NO20075600L NO 20075600 L NO20075600 L NO 20075600L NO 20075600 A NO20075600 A NO 20075600A NO 20075600 A NO20075600 A NO 20075600A NO 20075600 L NO20075600 L NO 20075600L
Authority
NO
Norway
Prior art keywords
dementia
prophylactic
disorder associated
behavioral disorder
nocturnal
Prior art date
Application number
NO20075600A
Other languages
English (en)
Norwegian (no)
Inventor
Keisuke Hirai
Masaomi Miyamoto
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37073568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20075600(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of NO20075600L publication Critical patent/NO20075600L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20075600A 2005-04-04 2007-11-05 Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens NO20075600L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005107673 2005-04-04
PCT/JP2006/307055 WO2006107027A1 (ja) 2005-04-04 2006-04-03 認知症に伴う夜間の行動障害の予防または治療剤

Publications (1)

Publication Number Publication Date
NO20075600L true NO20075600L (no) 2007-12-21

Family

ID=37073568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075600A NO20075600L (no) 2005-04-04 2007-11-05 Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens

Country Status (20)

Country Link
US (1) US20090306200A1 (es)
EP (1) EP1867642A4 (es)
JP (1) JP5244384B2 (es)
KR (1) KR20070118101A (es)
CN (1) CN101146787A (es)
AR (1) AR054246A1 (es)
AU (1) AU2006231759A1 (es)
BR (1) BRPI0609964A2 (es)
CA (1) CA2601988A1 (es)
CL (1) CL2009001914A1 (es)
CR (1) CR9376A (es)
IL (1) IL185936A0 (es)
MA (1) MA29400B1 (es)
MY (1) MY148806A (es)
NO (1) NO20075600L (es)
PE (1) PE20061292A1 (es)
RU (1) RU2007140876A (es)
TW (1) TW200637541A (es)
WO (1) WO2006107027A1 (es)
ZA (1) ZA200708444B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2488388C1 (ru) * 2012-05-24 2013-07-27 Ооо "Валента Интеллект" Фармацевтическая композиция для профилактики и лечения психических, поведенческих, когнитивных расстройств
WO2017119456A1 (ja) 2016-01-08 2017-07-13 武田薬品工業株式会社 せん妄の予防または治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3034239A (en) * 1961-04-05 1962-05-15 Arthur P Waterson Land leveler
US6638963B1 (en) * 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
JP3509637B2 (ja) * 1998-06-09 2004-03-22 武田薬品工業株式会社 睡眠障害予防治療剤
AU2003258147A1 (en) * 2002-08-08 2004-02-25 Irm Llc Methods for treating circadian rhythm phase disturbances

Also Published As

Publication number Publication date
EP1867642A4 (en) 2009-04-01
BRPI0609964A2 (pt) 2011-10-11
WO2006107027A1 (ja) 2006-10-12
TW200637541A (en) 2006-11-01
AR054246A1 (es) 2007-06-13
JPWO2006107027A1 (ja) 2008-09-25
JP5244384B2 (ja) 2013-07-24
RU2007140876A (ru) 2009-05-20
US20090306200A1 (en) 2009-12-10
CR9376A (es) 2007-12-07
EP1867642A1 (en) 2007-12-19
IL185936A0 (en) 2008-01-06
CL2009001914A1 (es) 2010-02-12
CN101146787A (zh) 2008-03-19
KR20070118101A (ko) 2007-12-13
MA29400B1 (fr) 2008-04-01
MY148806A (en) 2013-05-31
ZA200708444B (en) 2009-03-25
AU2006231759A1 (en) 2006-10-12
CA2601988A1 (en) 2006-10-12
PE20061292A1 (es) 2006-12-23

Similar Documents

Publication Publication Date Title
NO20075599L (no) Profylaktisk eller terapeutisk middel mot depresjon eller angstforstyrrelser
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
ATE356621T1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3- agonistisches therapeutikum
LTC1562603I2 (lt) Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui
NO20056130L (no) Nye substituerte 3-svovelindoler
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
EP1704161A4 (en) ON HELIX 12 OBJECTIVE STEROIDAL PHARMACEUTICAL PRODUCTS
MX2011008336A (es) Derivados de dihidroquinolinona.
WO2009071690A3 (de) 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
TN2012000092A1 (en) Therapeutic agent for mood disorders
PT2221298E (pt) Derivados de fenilpirazole
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
NO20075600L (no) Profylaktisk eller terapeutisk middel mot nattlig atferdsforstyrrelse assosiert med demens
ATE552251T1 (de) Thiophen- und furanverbindungen
EA200601449A1 (ru) Применение агомелатина для получения лекарственных средств, предназначенных для лечения нарушений сна у пациента с депрессией
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
SI1587584T1 (sl) Farmacevtska kombinacija za profilakso ali terapijo kardiovaskularnih, kardiopulmonalnih, pulmonalnih ali renalnih bolezni
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
ITRM20040300A1 (it) Trasduttore a geometria interdigitata per l'ottimizzazione del fascio acustico irradiato.
MY144089A (en) A medicament related to mirtazapine for the treatment of hot flush
FR2898272B1 (fr) Utilisation de derives du 3,5-seco-4-nor-cholestrane pour l'obtention d'un medicament cytoprotecteur
WO2010041271A3 (en) Process for preparation of (s)-n-[2-(1,6,7,8-tetrahydro-2h-indeno[5,4-b]furan-8-yl)ethyl] propionamide and novel intermediates thereof
UA2986U (uk) Спосіб лікування розсіяного склерозу
MX2007012219A (es) Medida de prevencion o remedio para neurosis paro depresion o ansiedad.
SE0102794D0 (sv) Medicament for the control of infections caused by pathogenic microorganisms

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application